NanoCement (NCTM)
Engineering the Future of Health.
Conlis Global Inc, a pioneering Canadian biotechnology company dedicated to advancing the field of tissue engineering and regenerative medicine. Our primary focus lies in developing groundbreaking solutions aimed at restoring tissue and organ function. Leveraging cutting-edge biomaterials and innovative manufacturing processes, we empower unparalleled design flexibility and intricate microarchitecture, facilitating enhanced biofunctionality. Beyond our commitment to innovation, we also offer comprehensive services, supporting small and medium enterprises in bridging the gap between research and market implementation. At Conlis Global, we’re not just shaping the future of biotechnology; we’re partnering with others to make impactful strides towards a healthier tomorrow.
About Us
CGI was founded by a team of like-minded professionals who are passionate about bringing innovative technologies to the commercial space. We have firsthand experience with the challenges and obstacles that many technologies face in the process of commercialization, including a lack of resources and commercial planning, a lack of the necessary skills and expertise, and a lack of understanding of regulatory and compliance standards. That’s why we’ve brought together a team of experts with diverse backgrounds and skills, who are dedicated to evaluating the potential of technologies for successful commercialization. At CGI, we are committed to bring innovative technologies to the world, and to making a positive impact through the strategic application of technology.
Pipeline
Conlis Globals clinical development program focuses on further developing NanoCement's properties, broadening clinical application areas and utilizing NanoCement's unique drug- releasing properties through the development of combination products that promote bone healing and avoid infections at the site of grafting.|
Several different combinations with NanoCement have been investigated to add osteoinductive properties, meaning the ability to actively stimulate bone healing. Among other things, the Company has conducted research in the form of preclinical candidates that have combined NanoCement with bone morphogenic proteins (BMP) and Zoledronic acid. BMP
Clinical Trials
Conlis Global Inc. has proven proficiency for establishment, execution and data compilation for clinical trials.
Regulatory Pathways
Conlis Global Inc. offers expert guidance for faster, efficient results with "System Focus" strategy.
Verification & Validation
Conlis Global Inc. has over a decade of expertise in planning and executing validation studies.
Lab Establishment
Conlis Global Inc. brings over a decade of expertise in establishing medical diagnostic facilities.
MVP To Market
Conlis Global Inc. closes the divide between scientific and regulatory realms with expertise and precision.
"CERAMENT: Explore, Learn, Connect Today!"
Explore our publications and resources page for key papers supporting our innovative CERAMENT bone graft substitutes. Contact us today!